Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2016 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Outcome variables in presymptomatic individuals at higher risk of developing Alzheimer disease.
Gauthier S, Montplaisir J, Petit D, Joanette Y, Feldman H, Mohr E, Nair NP, Poirier J. Gauthier S, et al. Alzheimer Dis Assoc Disord. 1996 Fall;10 Suppl 1:19-21. doi: 10.1097/00002093-199601031-00006. Alzheimer Dis Assoc Disord. 1996. PMID: 8876784
The treatment of individuals at risk of Alzheimer disease is feasible in well-designed, placebo-controlled, double-blind studies. The favored design would be life survival for cognitive impairment, alterations in instrumental ADL, and selected biologic …
The treatment of individuals at risk of Alzheimer disease is feasible in well-designed, placebo-controlled, doub …
Glucose level decline precedes dementia in elderly African Americans with diabetes.
Hendrie HC, Zheng M, Li W, Lane K, Ambuehl R, Purnell C, Unverzagt FW, Torke A, Balasubramanyam A, Callahan CM, Gao S. Hendrie HC, et al. Alzheimers Dement. 2017 Feb;13(2):111-118. doi: 10.1016/j.jalz.2016.08.017. Epub 2016 Oct 25. Alzheimers Dement. 2017. PMID: 27793691 Free PMC article.
Study endpoints were dementia, mild cognitive impairment (MCI), or normal cognition. Repeated serum glucose measurements were used as the outcome variables. RESULTS: Diabetic participants who developed incident dementia had a significant decrease in serum glu …
Study endpoints were dementia, mild cognitive impairment (MCI), or normal cognition. Repeated serum glucose measurements were used as the …
Feedback